Victory Pharma in deal for MiddleBrook assets; Submarine contractor may bid on Pfizer site;

 @FiercePharma: Pharma's 'aggressive' tax-avoidance tactics draw fire. Article | Follow @FiercePharma

> Victory buys bankrupt Middlebrook's assets.  News

> Mystic Seaport officials say the tourist attraction has decided not to bid on Pfizer's New London campus, but submarine contractor Electric Boat might still be interested in the 33-acre waterfront site. Report

> Members of the United Steel Workers International union Local 10-86 in Pennsylvania have voted to accept a three-year contract with Merck. Report

> Impax Laboratories got the FDA nod for its version of the Endo Pharmaceuticals' pain drug Opana. Release

> Danish biopharmaceuticals group Bavarian Nordic has begun deliveries of its Imvamune smallpox vaccine to the U.S. Strategic National Stockpile. Report

> Santarus said it appealed a U.S. district court ruling against it in a patent lawsuit versus Par Pharmaceuticals, sending shares of the specialty pharmaceutical company up 8 percent. Report

> Government efforts to raise at least $21 million by selling a 19.26 percent stake in Bosnia's top drug firm Bosnalijek failed in an offering on the Sarajevo Stock Exchange. Report

Biotech News

 @FierceBiotech: Wall Street to keep eye on Vertex data. Article |  Follow @FierceBiotech

@JohnCFierce: And speaking of hep C, the BBC does a closeup on Inhibitex's INX-189. Article | Follow @JohnCFierce

> Pharming to divest DNage, focus on Rhucin. Story

> Amgen eyes wider Dmab approval. Item

> Novo Nordisk shines among drugmakers. Report

Biotech IT News

> Pfizer mines data to find compounds for repurposing. Item

> OpenClinica gets case report form library. Story

> NCI grant targets trial design improvement. News

> Amazon answers biopharma's cloud interest. Article

> Lilly continues cloud computing efforts. Report

> Medidata, Aris combine EDC and safety systems. News

And Finally... Dartmouth College is getting $35 million to open a center it hopes will help the nation take the next big steps in healthcare reform: improving quality while lowering costs. Report